| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 48 | 2025 | 766 | 4.810 |
Why?
|
| Body Composition | 44 | 2024 | 521 | 3.960 |
Why?
|
| Water | 17 | 2025 | 186 | 3.520 |
Why?
|
| Oxygen Isotopes | 16 | 2024 | 35 | 2.730 |
Why?
|
| Deuterium | 19 | 2024 | 109 | 2.460 |
Why?
|
| Adipose Tissue | 18 | 2022 | 466 | 2.360 |
Why?
|
| Isoflavones | 7 | 2013 | 45 | 2.120 |
Why?
|
| Body Water | 22 | 2025 | 90 | 1.580 |
Why?
|
| Self Concept | 4 | 2016 | 155 | 1.560 |
Why?
|
| Exercise | 14 | 2023 | 816 | 1.500 |
Why?
|
| Obesity | 17 | 2023 | 2248 | 1.470 |
Why?
|
| Health Expenditures | 2 | 2023 | 103 | 1.460 |
Why?
|
| Body Weight | 20 | 2021 | 989 | 1.320 |
Why?
|
| Body Mass Index | 21 | 2025 | 1565 | 1.310 |
Why?
|
| Energy Intake | 18 | 2025 | 494 | 1.160 |
Why?
|
| Menopause | 3 | 2013 | 77 | 1.140 |
Why?
|
| beta-Glucans | 3 | 2013 | 17 | 1.100 |
Why?
|
| Hepatitis C, Chronic | 2 | 2021 | 327 | 1.090 |
Why?
|
| Dietary Supplements | 7 | 2021 | 473 | 1.060 |
Why?
|
| Health Care Costs | 4 | 2023 | 372 | 0.990 |
Why?
|
| Postmenopause | 3 | 2010 | 126 | 0.950 |
Why?
|
| Minority Groups | 5 | 2017 | 248 | 0.900 |
Why?
|
| Indicator Dilution Techniques | 6 | 2025 | 25 | 0.880 |
Why?
|
| Weight Loss | 8 | 2024 | 481 | 0.880 |
Why?
|
| Weight Reduction Programs | 3 | 2016 | 56 | 0.870 |
Why?
|
| Deuterium Oxide | 6 | 2024 | 17 | 0.860 |
Why?
|
| Quality of Life | 3 | 2023 | 1942 | 0.840 |
Why?
|
| Female | 104 | 2025 | 66787 | 0.800 |
Why?
|
| Camping | 3 | 2016 | 14 | 0.770 |
Why?
|
| Diet | 8 | 2019 | 1140 | 0.770 |
Why?
|
| Anthropometry | 6 | 2024 | 197 | 0.730 |
Why?
|
| Young Adult | 26 | 2025 | 9059 | 0.720 |
Why?
|
| Adult | 67 | 2025 | 29645 | 0.710 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 833 | 0.700 |
Why?
|
| Absorptiometry, Photon | 8 | 2022 | 178 | 0.700 |
Why?
|
| Humans | 135 | 2025 | 125156 | 0.690 |
Why?
|
| Male | 77 | 2025 | 61508 | 0.680 |
Why?
|
| Plant Extracts | 2 | 2012 | 121 | 0.680 |
Why?
|
| Bone Density | 6 | 2009 | 319 | 0.670 |
Why?
|
| Mass Spectrometry | 8 | 2015 | 332 | 0.630 |
Why?
|
| Diet, Carbohydrate-Restricted | 5 | 2024 | 25 | 0.620 |
Why?
|
| Middle Aged | 39 | 2025 | 26939 | 0.620 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2018 | 7 | 0.610 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 930 | 0.610 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2023 | 112 | 0.600 |
Why?
|
| Basal Metabolism | 11 | 2023 | 95 | 0.590 |
Why?
|
| Dementia | 1 | 2023 | 452 | 0.580 |
Why?
|
| Isotope Labeling | 8 | 2022 | 105 | 0.580 |
Why?
|
| Hydrogen | 6 | 2012 | 41 | 0.560 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 1314 | 0.550 |
Why?
|
| Milk, Human | 7 | 2015 | 300 | 0.530 |
Why?
|
| Infant Nutritional Physiological Phenomena | 4 | 2015 | 193 | 0.530 |
Why?
|
| Cost of Illness | 2 | 2021 | 252 | 0.530 |
Why?
|
| Ontario | 5 | 2023 | 64 | 0.520 |
Why?
|
| Adolescent | 32 | 2025 | 19356 | 0.520 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 3428 | 0.520 |
Why?
|
| Community Health Services | 2 | 2016 | 89 | 0.510 |
Why?
|
| Breast Feeding | 6 | 2019 | 220 | 0.510 |
Why?
|
| Overweight | 6 | 2018 | 364 | 0.500 |
Why?
|
| Kidney Failure, Chronic | 3 | 2013 | 880 | 0.490 |
Why?
|
| Urinalysis | 1 | 2015 | 61 | 0.490 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 29 | 0.480 |
Why?
|
| Diet, Reducing | 2 | 2020 | 89 | 0.480 |
Why?
|
| Self Report | 6 | 2025 | 518 | 0.470 |
Why?
|
| Health Promotion | 2 | 2016 | 389 | 0.460 |
Why?
|
| Sleep | 3 | 2016 | 345 | 0.460 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2011 | 24 | 0.450 |
Why?
|
| Reproducibility of Results | 13 | 2017 | 2892 | 0.440 |
Why?
|
| Child | 29 | 2025 | 24394 | 0.430 |
Why?
|
| Nephrotic Syndrome | 1 | 2013 | 48 | 0.420 |
Why?
|
| Antiviral Agents | 2 | 2021 | 752 | 0.400 |
Why?
|
| Aged | 22 | 2025 | 19878 | 0.390 |
Why?
|
| Aged, 80 and over | 8 | 2025 | 6603 | 0.390 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2012 | 93 | 0.390 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 79 | 0.380 |
Why?
|
| Nutritional Status | 2 | 2015 | 314 | 0.380 |
Why?
|
| Peritoneal Dialysis | 2 | 2012 | 117 | 0.370 |
Why?
|
| Child, Preschool | 20 | 2025 | 14011 | 0.370 |
Why?
|
| Models, Biological | 13 | 2014 | 1460 | 0.370 |
Why?
|
| Phytoestrogens | 2 | 2010 | 16 | 0.370 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 74 | 0.360 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 144 | 0.360 |
Why?
|
| Nutritional Requirements | 7 | 2018 | 181 | 0.350 |
Why?
|
| Age Factors | 6 | 2024 | 2821 | 0.340 |
Why?
|
| Blood Pressure | 3 | 2017 | 1372 | 0.340 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 99 | 0.340 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2016 | 173 | 0.330 |
Why?
|
| Liver Transplantation | 2 | 2021 | 1036 | 0.320 |
Why?
|
| Behavior Therapy | 1 | 2012 | 255 | 0.320 |
Why?
|
| Cohort Studies | 8 | 2022 | 4820 | 0.320 |
Why?
|
| Vitamin B Complex | 1 | 2009 | 41 | 0.310 |
Why?
|
| Adiposity | 3 | 2021 | 190 | 0.310 |
Why?
|
| Nitric Oxide | 1 | 2012 | 493 | 0.310 |
Why?
|
| Infant | 22 | 2022 | 12483 | 0.300 |
Why?
|
| Sex Factors | 6 | 2017 | 1288 | 0.300 |
Why?
|
| Program Evaluation | 6 | 2016 | 443 | 0.300 |
Why?
|
| Mammography | 1 | 2009 | 114 | 0.300 |
Why?
|
| Breast | 2 | 2009 | 214 | 0.290 |
Why?
|
| Double-Blind Method | 5 | 2013 | 1638 | 0.290 |
Why?
|
| Infant, Newborn | 25 | 2022 | 8209 | 0.290 |
Why?
|
| Extracellular Space | 3 | 2000 | 87 | 0.280 |
Why?
|
| Pregnancy, Twin | 2 | 2018 | 180 | 0.270 |
Why?
|
| Canada | 2 | 2021 | 288 | 0.270 |
Why?
|
| Proteins | 6 | 2018 | 1036 | 0.270 |
Why?
|
| Placebos | 4 | 2013 | 241 | 0.270 |
Why?
|
| Dietary Proteins | 5 | 2015 | 252 | 0.260 |
Why?
|
| Bromides | 2 | 2000 | 4 | 0.260 |
Why?
|
| Hepatitis C | 2 | 2021 | 365 | 0.250 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 3733 | 0.250 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1526 | 0.250 |
Why?
|
| Puberty | 2 | 2023 | 95 | 0.250 |
Why?
|
| Diet Surveys | 2 | 2016 | 98 | 0.250 |
Why?
|
| Calibration | 3 | 2022 | 89 | 0.230 |
Why?
|
| Life Style | 2 | 2022 | 416 | 0.230 |
Why?
|
| Athletes | 1 | 2025 | 66 | 0.230 |
Why?
|
| Urine | 3 | 2012 | 90 | 0.220 |
Why?
|
| Plethysmography | 3 | 2012 | 35 | 0.220 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2003 | 3 | 0.220 |
Why?
|
| School Health Services | 2 | 2016 | 99 | 0.210 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 1143 | 0.210 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 2512 | 0.210 |
Why?
|
| Motor Activity | 5 | 2014 | 521 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2003 | 24 | 0.210 |
Why?
|
| Dietary Carbohydrates | 3 | 2020 | 119 | 0.210 |
Why?
|
| Infant, Premature | 5 | 2012 | 820 | 0.210 |
Why?
|
| Phantoms, Imaging | 1 | 2004 | 134 | 0.210 |
Why?
|
| Survivors | 2 | 2015 | 339 | 0.200 |
Why?
|
| Drinking | 1 | 2022 | 34 | 0.200 |
Why?
|
| Health Services | 1 | 2023 | 71 | 0.200 |
Why?
|
| Pregnancy | 15 | 2022 | 7201 | 0.200 |
Why?
|
| Salvage Therapy | 1 | 2004 | 192 | 0.200 |
Why?
|
| Regression Analysis | 6 | 2016 | 781 | 0.200 |
Why?
|
| Birth Weight | 4 | 2018 | 345 | 0.190 |
Why?
|
| Hypocotyl | 2 | 2012 | 6 | 0.190 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.190 |
Why?
|
| Poverty | 2 | 2016 | 423 | 0.190 |
Why?
|
| Heart Failure, Systolic | 1 | 2022 | 34 | 0.190 |
Why?
|
| Longitudinal Studies | 7 | 2022 | 1327 | 0.190 |
Why?
|
| Sexual Behavior | 1 | 2023 | 247 | 0.190 |
Why?
|
| Residence Characteristics | 2 | 2014 | 278 | 0.180 |
Why?
|
| Lasers | 1 | 2022 | 114 | 0.180 |
Why?
|
| Malnutrition | 2 | 2021 | 205 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 871 | 0.180 |
Why?
|
| Texas | 4 | 2014 | 3588 | 0.180 |
Why?
|
| Eating | 2 | 2017 | 368 | 0.180 |
Why?
|
| Income | 1 | 2021 | 134 | 0.180 |
Why?
|
| Urban Population | 4 | 2014 | 226 | 0.180 |
Why?
|
| Body Fluid Compartments | 2 | 2018 | 19 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 510 | 0.170 |
Why?
|
| Health Resources | 1 | 2021 | 116 | 0.170 |
Why?
|
| Plasma Volume | 1 | 2000 | 15 | 0.170 |
Why?
|
| Women's Health | 2 | 2012 | 134 | 0.170 |
Why?
|
| Accelerometry | 3 | 2018 | 60 | 0.170 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 383 | 0.170 |
Why?
|
| Breeding | 1 | 1999 | 20 | 0.170 |
Why?
|
| International Agencies | 1 | 2019 | 29 | 0.170 |
Why?
|
| Water Supply | 1 | 2019 | 26 | 0.170 |
Why?
|
| Nutritive Value | 2 | 2012 | 91 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2019 | 34 | 0.160 |
Why?
|
| Hepacivirus | 1 | 2021 | 244 | 0.160 |
Why?
|
| Mass Screening | 2 | 2018 | 785 | 0.160 |
Why?
|
| Mutation | 1 | 2013 | 5848 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1999 | 32 | 0.160 |
Why?
|
| Ovariectomy | 1 | 2000 | 183 | 0.160 |
Why?
|
| Minerals | 2 | 1998 | 57 | 0.160 |
Why?
|
| Insulin | 3 | 2018 | 1204 | 0.160 |
Why?
|
| Linear Models | 6 | 2016 | 683 | 0.160 |
Why?
|
| Sheep | 1 | 1999 | 220 | 0.160 |
Why?
|
| Weight Gain | 7 | 2022 | 400 | 0.160 |
Why?
|
| Literature, Modern | 1 | 2018 | 2 | 0.150 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 42 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 1968 | 0.150 |
Why?
|
| Hospitals | 1 | 2021 | 389 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2022 | 1179 | 0.150 |
Why?
|
| United States | 5 | 2023 | 10916 | 0.150 |
Why?
|
| Body Height | 2 | 2018 | 215 | 0.140 |
Why?
|
| Risk Factors | 6 | 2018 | 10310 | 0.140 |
Why?
|
| Social Class | 2 | 2022 | 190 | 0.140 |
Why?
|
| Aging | 2 | 2022 | 1185 | 0.140 |
Why?
|
| Health Education | 3 | 2009 | 222 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1999 | 341 | 0.140 |
Why?
|
| Cholesterol | 3 | 1995 | 541 | 0.140 |
Why?
|
| Potassium, Dietary | 1 | 2017 | 12 | 0.140 |
Why?
|
| Sodium, Dietary | 1 | 2017 | 35 | 0.140 |
Why?
|
| Heart Failure | 2 | 2022 | 2297 | 0.140 |
Why?
|
| Fetal Development | 1 | 2018 | 132 | 0.140 |
Why?
|
| Analysis of Variance | 6 | 2004 | 1020 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2018 | 381 | 0.130 |
Why?
|
| Skinfold Thickness | 2 | 2015 | 31 | 0.130 |
Why?
|
| Reproduction | 3 | 2023 | 236 | 0.130 |
Why?
|
| Photography | 1 | 2017 | 95 | 0.130 |
Why?
|
| Carbon Dioxide | 11 | 1994 | 278 | 0.130 |
Why?
|
| Biological Availability | 2 | 2011 | 137 | 0.130 |
Why?
|
| Food | 3 | 2017 | 125 | 0.130 |
Why?
|
| Sugars | 1 | 2016 | 15 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2023 | 16334 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 83 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2016 | 42 | 0.130 |
Why?
|
| Seasons | 2 | 2013 | 312 | 0.130 |
Why?
|
| Caregivers | 1 | 2021 | 575 | 0.130 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2000 | 66 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 614 | 0.130 |
Why?
|
| Nitrogen | 2 | 2015 | 146 | 0.130 |
Why?
|
| Pandemics | 1 | 2023 | 1105 | 0.120 |
Why?
|
| Calorimetry, Indirect | 4 | 2021 | 56 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2018 | 471 | 0.120 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 33 | 0.120 |
Why?
|
| Soybean Proteins | 2 | 2011 | 17 | 0.120 |
Why?
|
| Prevalence | 3 | 2018 | 2455 | 0.120 |
Why?
|
| Sri Lanka | 1 | 2015 | 9 | 0.120 |
Why?
|
| Child Health Services | 1 | 2016 | 87 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1547 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 133 | 0.120 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 23 | 0.110 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 271 | 0.110 |
Why?
|
| New Zealand | 1 | 2013 | 50 | 0.110 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 5177 | 0.110 |
Why?
|
| Founder Effect | 1 | 2013 | 32 | 0.110 |
Why?
|
| Heart Rate | 3 | 2014 | 592 | 0.110 |
Why?
|
| British Columbia | 2 | 2023 | 8 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 1025 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2018 | 12392 | 0.100 |
Why?
|
| Animals | 11 | 2022 | 34224 | 0.100 |
Why?
|
| Research Design | 3 | 2024 | 695 | 0.100 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 119 | 0.100 |
Why?
|
| Platinum | 1 | 2012 | 12 | 0.100 |
Why?
|
| Gases | 1 | 2012 | 16 | 0.100 |
Why?
|
| Markov Chains | 1 | 2013 | 84 | 0.100 |
Why?
|
| Hypercholesterolemia | 1 | 1995 | 230 | 0.100 |
Why?
|
| Cats | 1 | 2012 | 119 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 185 | 0.100 |
Why?
|
| Catalysis | 1 | 2012 | 127 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 40 | 0.100 |
Why?
|
| Time Factors | 4 | 2013 | 6333 | 0.100 |
Why?
|
| Renal Replacement Therapy | 1 | 2013 | 142 | 0.100 |
Why?
|
| Infant Food | 5 | 2007 | 81 | 0.100 |
Why?
|
| Zinc | 1 | 2012 | 134 | 0.090 |
Why?
|
| Equol | 1 | 2011 | 4 | 0.090 |
Why?
|
| Prospective Studies | 7 | 2021 | 6158 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 241 | 0.090 |
Why?
|
| Physical Fitness | 2 | 2009 | 90 | 0.090 |
Why?
|
| Tritium | 1 | 1991 | 173 | 0.090 |
Why?
|
| Neoplasms | 2 | 2015 | 2794 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2012 | 340 | 0.090 |
Why?
|
| Endometrium | 1 | 2013 | 281 | 0.090 |
Why?
|
| Lactation | 4 | 1997 | 192 | 0.090 |
Why?
|
| Prognosis | 3 | 2015 | 4642 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 1437 | 0.080 |
Why?
|
| Risk | 1 | 2012 | 756 | 0.080 |
Why?
|
| Thiamine | 1 | 2009 | 8 | 0.080 |
Why?
|
| Phenotype | 2 | 2023 | 4263 | 0.080 |
Why?
|
| Electric Conductivity | 4 | 2002 | 87 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 438 | 0.080 |
Why?
|
| Vitamin B 12 | 1 | 2009 | 59 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2022 | 313 | 0.080 |
Why?
|
| Riboflavin | 1 | 2009 | 38 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 186 | 0.080 |
Why?
|
| Carbon Isotopes | 5 | 1996 | 277 | 0.080 |
Why?
|
| Oxygen | 2 | 1999 | 555 | 0.080 |
Why?
|
| Gestational Age | 4 | 2018 | 1163 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 941 | 0.070 |
Why?
|
| Nutrition Surveys | 2 | 2025 | 293 | 0.070 |
Why?
|
| Vitamin D | 1 | 2009 | 161 | 0.070 |
Why?
|
| Lactose | 2 | 2005 | 54 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 22 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 433 | 0.070 |
Why?
|
| Incidence | 2 | 2012 | 3146 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 2064 | 0.070 |
Why?
|
| Guanidines | 1 | 1987 | 26 | 0.070 |
Why?
|
| Reference Values | 3 | 2018 | 715 | 0.070 |
Why?
|
| Mathematics | 7 | 2003 | 96 | 0.070 |
Why?
|
| Bias | 2 | 2015 | 131 | 0.070 |
Why?
|
| Cognition | 1 | 2012 | 731 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 1987 | 81 | 0.070 |
Why?
|
| Body Fluids | 1 | 1987 | 47 | 0.070 |
Why?
|
| Saliva | 1 | 1987 | 114 | 0.070 |
Why?
|
| Electroacupuncture | 1 | 2006 | 8 | 0.070 |
Why?
|
| Health Behavior | 1 | 2009 | 385 | 0.070 |
Why?
|
| Gastric Emptying | 1 | 2006 | 79 | 0.060 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2006 | 20 | 0.060 |
Why?
|
| Carbon | 2 | 1985 | 92 | 0.060 |
Why?
|
| HIV Antibodies | 1 | 2006 | 69 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3572 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1697 | 0.060 |
Why?
|
| Sports Nutritional Physiological Phenomena | 1 | 2025 | 1 | 0.060 |
Why?
|
| Electric Impedance | 4 | 2001 | 63 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2006 | 111 | 0.060 |
Why?
|
| Homosexuality, Male | 1 | 2005 | 64 | 0.060 |
Why?
|
| Indians, North American | 2 | 1997 | 58 | 0.060 |
Why?
|
| Lactase | 1 | 2005 | 40 | 0.060 |
Why?
|
| Syphilis | 1 | 2005 | 96 | 0.060 |
Why?
|
| Radiodermatitis | 1 | 2004 | 7 | 0.060 |
Why?
|
| Leptin | 3 | 2015 | 214 | 0.060 |
Why?
|
| Calcium | 1 | 2009 | 1102 | 0.060 |
Why?
|
| Bicarbonates | 6 | 1991 | 98 | 0.060 |
Why?
|
| Femur Neck | 1 | 2004 | 9 | 0.060 |
Why?
|
| Postpartum Period | 3 | 2018 | 215 | 0.050 |
Why?
|
| Hip Joint | 1 | 2004 | 37 | 0.050 |
Why?
|
| Mammaplasty | 1 | 2004 | 53 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2006 | 537 | 0.050 |
Why?
|
| Swine | 3 | 1993 | 1207 | 0.050 |
Why?
|
| San Francisco | 1 | 2003 | 17 | 0.050 |
Why?
|
| Femur | 1 | 2004 | 67 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2023 | 24 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 321 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2006 | 258 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2004 | 112 | 0.050 |
Why?
|
| Spine | 1 | 2004 | 142 | 0.050 |
Why?
|
| Actigraphy | 2 | 2014 | 45 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2004 | 255 | 0.050 |
Why?
|
| Humidity | 1 | 2022 | 25 | 0.050 |
Why?
|
| Biomarkers | 3 | 2017 | 3090 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2007 | 852 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3157 | 0.050 |
Why?
|
| Calorimetry | 3 | 1994 | 62 | 0.050 |
Why?
|
| Thinness | 1 | 2003 | 70 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 464 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2004 | 203 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2004 | 344 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2011 | 3466 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2022 | 65 | 0.050 |
Why?
|
| Oxygen Consumption | 4 | 2010 | 305 | 0.050 |
Why?
|
| Sierra Leone | 1 | 2021 | 30 | 0.050 |
Why?
|
| Software | 2 | 2004 | 683 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 257 | 0.050 |
Why?
|
| Health Personnel | 1 | 2005 | 504 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 285 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2000 | 119 | 0.040 |
Why?
|
| Overnutrition | 1 | 2019 | 12 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 1999 | 39 | 0.040 |
Why?
|
| Kinetics | 6 | 1995 | 1332 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1999 | 89 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 778 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 1999 | 149 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2056 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 1999 | 144 | 0.040 |
Why?
|
| Animal Feed | 1 | 1999 | 77 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 1 | 1999 | 87 | 0.040 |
Why?
|
| Dietary Fats | 2 | 2017 | 294 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2022 | 946 | 0.040 |
Why?
|
| Growth | 1 | 1999 | 106 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 57 | 0.040 |
Why?
|
| Breath Tests | 7 | 1991 | 178 | 0.040 |
Why?
|
| Physical Examination | 1 | 1999 | 159 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 90 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2017 | 1196 | 0.040 |
Why?
|
| Lysine | 2 | 1991 | 196 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2018 | 21 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 42 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 122 | 0.040 |
Why?
|
| Hunger | 1 | 2017 | 46 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2012 | 256 | 0.040 |
Why?
|
| Medical Records | 2 | 2012 | 192 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2015 | 1398 | 0.030 |
Why?
|
| Torso | 1 | 2017 | 12 | 0.030 |
Why?
|
| Time | 1 | 2017 | 92 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 89 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2023 | 854 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 244 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 55 | 0.030 |
Why?
|
| Acceleration | 2 | 2012 | 26 | 0.030 |
Why?
|
| Fructose | 1 | 2016 | 62 | 0.030 |
Why?
|
| Maintenance Chemotherapy | 1 | 2015 | 20 | 0.030 |
Why?
|
| Boston | 1 | 2015 | 109 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 136 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 355 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 592 | 0.030 |
Why?
|
| Absorption | 1 | 1995 | 52 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 19 | 0.030 |
Why?
|
| Blood Glucose | 1 | 1999 | 1133 | 0.030 |
Why?
|
| Ergometry | 1 | 1994 | 5 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 23 | 0.030 |
Why?
|
| Intestinal Absorption | 5 | 2005 | 190 | 0.030 |
Why?
|
| Remission Induction | 1 | 2015 | 300 | 0.030 |
Why?
|
| Rats | 2 | 2000 | 3717 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 59 | 0.030 |
Why?
|
| Physical Exertion | 2 | 2010 | 78 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 136 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 522 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 51 | 0.030 |
Why?
|
| HIV Infections | 1 | 2006 | 1897 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1995 | 220 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 55 | 0.030 |
Why?
|
| Cholesterol, HDL | 2 | 2012 | 358 | 0.030 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1994 | 18 | 0.030 |
Why?
|
| Potassium | 2 | 2007 | 282 | 0.030 |
Why?
|
| Triglycerides | 2 | 2012 | 575 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1114 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 1993 | 152 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2012 | 19 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2014 | 178 | 0.020 |
Why?
|
| Lactation Disorders | 1 | 1992 | 3 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 1995 | 235 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2012 | 218 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 900 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2012 | 3300 | 0.020 |
Why?
|
| Chemistry | 1 | 1991 | 60 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1991 | 85 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 315 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 780 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 761 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1241 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1361 | 0.020 |
Why?
|
| Anions | 1 | 1989 | 19 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 1989 | 50 | 0.020 |
Why?
|
| Administration, Oral | 3 | 2006 | 684 | 0.020 |
Why?
|
| Equipment Design | 2 | 2006 | 599 | 0.020 |
Why?
|
| Wakefulness | 1 | 2010 | 98 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 343 | 0.020 |
Why?
|
| Flour | 1 | 2007 | 7 | 0.020 |
Why?
|
| Microchemistry | 1 | 1987 | 7 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1984 | 257 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 45 | 0.020 |
Why?
|
| Oxygen Radioisotopes | 1 | 1987 | 4 | 0.020 |
Why?
|
| Guanidine | 1 | 1987 | 10 | 0.020 |
Why?
|
| Zea mays | 1 | 2007 | 43 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2012 | 640 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 1534 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2064 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 75 | 0.020 |
Why?
|
| Food, Fortified | 1 | 2007 | 96 | 0.020 |
Why?
|
| Glucans | 1 | 1986 | 11 | 0.020 |
Why?
|
| Bottle Feeding | 1 | 2006 | 36 | 0.020 |
Why?
|
| Dextropropoxyphene | 1 | 2006 | 3 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2006 | 176 | 0.020 |
Why?
|
| HIV Seroprevalence | 1 | 2006 | 9 | 0.020 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2006 | 17 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2006 | 26 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1694 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1989 | 1016 | 0.020 |
Why?
|
| Narcotics | 1 | 2006 | 64 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1985 | 21 | 0.020 |
Why?
|
| Malawi | 1 | 2007 | 396 | 0.020 |
Why?
|
| Morphine | 1 | 2006 | 83 | 0.020 |
Why?
|
| California | 1 | 2006 | 128 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1985 | 51 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 1433 | 0.020 |
Why?
|
| Fatty Acids, Volatile | 1 | 1985 | 33 | 0.020 |
Why?
|
| Infant Formula | 1 | 2006 | 96 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 162 | 0.020 |
Why?
|
| Aminopyrine | 1 | 1985 | 7 | 0.020 |
Why?
|
| Intestine, Small | 2 | 2005 | 307 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 72 | 0.020 |
Why?
|
| Lactose Intolerance | 1 | 2005 | 9 | 0.010 |
Why?
|
| Acetaminophen | 1 | 2006 | 92 | 0.010 |
Why?
|
| Preventive Health Services | 1 | 2005 | 61 | 0.010 |
Why?
|
| Digestion | 1 | 2005 | 41 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2007 | 267 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2006 | 143 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2006 | 346 | 0.010 |
Why?
|
| Mastectomy | 1 | 2004 | 64 | 0.010 |
Why?
|
| Glucose | 2 | 1986 | 877 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 144 | 0.010 |
Why?
|
| Methods | 1 | 2003 | 149 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2004 | 183 | 0.010 |
Why?
|
| Perfusion | 1 | 2005 | 207 | 0.010 |
Why?
|
| Edible Grain | 1 | 1983 | 45 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 334 | 0.010 |
Why?
|
| Feces | 2 | 1983 | 727 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 351 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 518 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 1110 | 0.010 |
Why?
|
| Paracoccus denitrificans | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 569 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 1662 | 0.010 |
Why?
|
| Leucine | 1 | 1996 | 310 | 0.010 |
Why?
|
| Child Development | 1 | 1997 | 266 | 0.010 |
Why?
|
| Rest | 1 | 1994 | 58 | 0.010 |
Why?
|
| Sodium Bicarbonate | 2 | 1985 | 55 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1994 | 46 | 0.010 |
Why?
|
| Plant Preparations | 1 | 1994 | 18 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1986 | 443 | 0.010 |
Why?
|
| Weaning | 1 | 1993 | 44 | 0.010 |
Why?
|
| Exercise Test | 1 | 1994 | 254 | 0.010 |
Why?
|
| Respiration | 2 | 1984 | 119 | 0.010 |
Why?
|
| Milk | 1 | 1994 | 119 | 0.010 |
Why?
|
| Body Constitution | 1 | 1992 | 36 | 0.010 |
Why?
|
| Mexico | 1 | 1992 | 181 | 0.010 |
Why?
|
| Estrogens | 1 | 1994 | 504 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1988 | 43 | 0.000 |
Why?
|
| Genotype | 1 | 1993 | 2564 | 0.000 |
Why?
|
| Electromagnetic Phenomena | 1 | 1986 | 4 | 0.000 |
Why?
|
| Half-Life | 1 | 1986 | 158 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1986 | 75 | 0.000 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1985 | 11 | 0.000 |
Why?
|
| Acetates | 1 | 1985 | 74 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1986 | 581 | 0.000 |
Why?
|
| Rectum | 1 | 1985 | 99 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 100 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 440 | 0.000 |
Why?
|
| Rabbits | 1 | 1985 | 718 | 0.000 |
Why?
|
| Nutrition Disorders | 1 | 1984 | 32 | 0.000 |
Why?
|
| Sodium | 1 | 1985 | 297 | 0.000 |
Why?
|
| Colon | 1 | 1983 | 350 | 0.000 |
Why?
|
| Liver | 1 | 1985 | 1745 | 0.000 |
Why?
|